ITT Stock Cash Flow Statements

ITT Quarterly Cash Flow Statements Chart

Quarterly

Annual

Capital Expenditure

ITT Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-28	2025-03-29	2024-12-31	2024-09-28	2024-06-29	2024-03-30	2023-12-31	2023-09-30	2023-07-01	2023-04-01	2022-12-31	2022-10-01	2022-07-02	2022-04-02	2021-12-31	2021-10-02	2021-07-03	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31

operating activities																																																-14,700,000	-300,000	-3,400,000	1,500,000	-1,000,000
income from continuing operations attributable to itt inc.	121,000,000	108,400,000	126,900,000	161,300,000	119,200,000	111,000,000	92,400,000	110,800,000	108,200,000	100,000,000	115,200,000	102,500,000	75,800,000	74,800,000	103,000,000	86,600,000	39,000,000	86,200,000	-13,600,000	-48,000,000	46,400,000	83,700,000	66,500,000	118,700,000	66,900,000	71,300,000	50,600,000	111,000,000	69,700,000	101,100,000	-66,000,000	87,000,000	47,900,000	46,100,000	23,600,000	88,300,000
adjustments to income from continuing operations:
depreciation and amortization	35,500,000	37,200,000	36,600,000	34,700,000	32,400,000	33,600,000	26,400,000	29,000,000	27,100,000	26,700,000	25,900,000	26,200,000	28,000,000	27,300,000	27,800,000	28,100,000	28,700,000	28,500,000	30,200,000	27,500,000	27,100,000	27,400,000	32,300,000	28,100,000	26,600,000	26,400,000	26,900,000	27,300,000	27,600,000	27,600,000	27,700,000	27,200,000	25,600,000	24,800,000	25,500,000	25,400,000	25,800,000	25,300,000	26,900,000	21,200,000	21,200,000	20,700,000	24,100,000	22,000,000	21,100,000	21,100,000	20,400,000	21,900,000	19,400,000	17,700,000	17,000,000	17,000,000	-183,000,000	85,000,000	88,000,000	84,000,000
equity-based compensation	9,300,000	7,900,000	6,100,000	6,100,000	6,700,000	7,000,000	5,100,000	5,000,000	5,400,000	4,700,000	4,500,000	4,900,000	5,000,000	3,700,000	4,700,000	4,400,000	4,100,000	3,300,000	3,700,000	3,900,000	3,300,000	2,500,000	3,400,000	3,900,000	3,900,000	4,500,000	4,700,000	6,700,000	5,700,000	4,500,000
other non-cash charges	7,900,000	6,300,000	6,700,000	8,100,000	7,600,000	8,100,000	14,600,000	5,900,000	9,100,000	7,500,000	7,300,000	2,900,000	7,100,000	10,200,000	3,400,000	6,700,000	4,900,000	6,300,000	11,500,000	10,000,000	12,500,000	11,000,000	13,000,000	10,500,000
changes in assets and liabilities:
change in receivables	-8,400,000	-43,200,000	50,300,000	-33,100,000	7,300,000	-67,700,000	15,500,000	3,900,000	-23,900,000	-34,700,000	30,100,000	-43,200,000	-6,900,000	-70,700,000	800,000	-11,400,000	-1,500,000	-50,100,000	5,500,000	-19,400,000	110,600,000	-13,400,000		11,000,000	-5,800,000	-47,100,000		-8,300,000	-1,900,000	-13,300,000		-11,600,000	-900,000	-34,700,000	36,400,000	31,700,000	-24,600,000	-21,000,000		-5,400,000	-15,100,000	-56,700,000		-14,200,000	20,700,000	-100,000,000		-42,300,000	42,200,000	1,000,000	7,100,000	-68,000,000	179,000,000	-38,000,000	-113,000,000	-102,000,000
change in inventories	-6,300,000	-5,600,000	4,600,000	2,500,000	-4,100,000	-1,000,000	6,500,000	-9,500,000	-2,300,000	-29,100,000	11,800,000	-4,800,000	-58,100,000	-48,400,000	-20,100,000	-11,800,000	-29,600,000	-21,200,000	22,700,000	11,800,000	1,400,000	600,000		-800,000	-10,100,000	-17,300,000		600,000	-2,100,000	-20,700,000	18,400,000	-6,500,000	3,900,000	-1,600,000		-5,200,000	300,000	-4,000,000	37,800,000	-8,300,000	-1,600,000	3,600,000		-12,100,000	-19,800,000	25,600,000		25,600,000	5,700,000	-6,300,000	2,900,000	-11,000,000	108,000,000	-47,000,000	-23,000,000	-76,000,000
change in contract assets	600,000	-6,600,000	-2,900,000	15,700,000	-7,200,000	-13,500,000	-800,000	3,400,000	-900,000	-2,000,000	8,200,000	-4,700,000	-9,200,000	-1,700,000					-1,400,000				16,100,000
change in contract liabilities	18,900,000	15,900,000	700,000	-17,100,000	12,200,000	3,300,000	12,000,000	-900,000	9,100,000	2,900,000	-1,100,000	5,700,000	6,900,000	11,800,000					-3,600,000
change in accounts payable	-25,800,000	16,500,000	13,200,000	-19,600,000	-6,800,000	15,000,000	9,800,000	7,600,000	7,100,000	1,800,000	-14,600,000	-11,300,000	16,700,000	48,600,000	29,500,000	16,000,000	-4,500,000	36,600,000	100,000	27,500,000	-55,900,000	-6,400,000		-7,800,000	-7,400,000	18,800,000		3,900,000	-24,600,000	10,400,000	13,400,000	11,200,000	-10,300,000	2,500,000	16,900,000	-11,900,000	10,500,000	-14,800,000	11,400,000	-4,900,000	5,000,000	-500,000		1,600,000	-2,200,000	1,800,000	100,000	-11,000,000	7,600,000	-16,400,000	-6,500,000	11,000,000	-133,000,000	25,000,000	125,000,000	-13,000,000
change in accrued expenses	23,300,000	-31,700,000	3,300,000	12,000,000	18,400,000	-44,500,000	18,200,000	13,900,000	26,300,000	-10,800,000	-6,300,000	2,400,000	9,500,000	-42,500,000	6,300,000	-3,400,000	27,400,000	-14,500,000	-11,000,000	9,500,000	30,900,000	-25,200,000		20,900,000	1,400,000	-29,500,000	13,000,000	15,700,000	8,200,000	-31,200,000	-1,100,000	21,600,000	200,000	-3,500,000		9,300,000	700,000	-28,800,000		-6,500,000	1,700,000	-21,300,000		7,600,000	6,000,000	-9,500,000	44,000,000	1,500,000	2,200,000	-3,600,000	5,300,000	-14,000,000
change in income taxes	-16,400,000	11,800,000	13,300,000	-1,800,000	-23,700,000	10,100,000	7,500,000	6,000,000	-11,800,000	3,700,000	-1,400,000	-8,600,000	-13,600,000	10,100,000	-121,200,000	6,300,000	112,700,000	10,400,000	57,700,000	-46,400,000	-34,000,000	16,500,000		19,600,000	-5,800,000	9,500,000
other	-5,900,000	-3,500,000	-15,500,000	2,900,000	-4,300,000	-3,600,000	-16,300,000	-5,300,000	-6,500,000	-12,600,000	5,500,000	-11,000,000	-4,300,000	-25,900,000	-13,800,000	-7,400,000	-5,900,000	-15,500,000	-13,000,000	3,600,000	-7,200,000	-12,700,000	9,800,000	19,500,000	-26,900,000	-2,200,000	-5,000,000	9,000,000	10,600,000	-3,600,000		300,000	-3,100,000	-7,500,000	24,400,000	-8,200,000	3,800,000	-3,500,000	3,200,000	8,300,000	-100,000	-8,100,000	25,300,000	-2,200,000	13,600,000	-300,000	21,000,000	-21,300,000	19,500,000	-1,000,000	10,700,000	22,000,000	-59,000,000	136,000,000	-69,000,000	-61,000,000
net cash – operating activities	153,700,000	113,400,000	223,200,000	123,900,000	157,700,000	57,800,000	170,400,000	169,800,000	139,700,000	58,100,000	162,500,000	61,000,000	56,900,000	-2,700,000	119,500,000	103,700,000	-302,400,000	70,800,000	117,800,000	115,000,000	149,600,000	53,500,000	136,000,000	120,600,000	59,000,000	42,100,000	125,200,000	127,300,000	76,900,000	42,400,000	69,000,000	85,700,000	65,600,000	27,100,000	94,000,000	75,100,000	65,900,000	5,700,000	82,600,000	57,600,000	81,300,000	8,200,000	112,800,000	47,600,000	97,500,000	-13,200,000	128,000,000	29,800,000	70,000,000	74,000,000	85,100,000	18,000,000	-775,000,000	248,000,000	184,000,000	20,000,000
investing activities
capital expenditures	-16,400,000	-36,800,000	-36,400,000	-36,600,000	-23,200,000	-27,700,000	-39,100,000	-22,200,000	-17,600,000	-28,700,000	-30,200,000	-26,200,000	-17,500,000	-30,000,000	-35,800,000	-17,500,000	-17,900,000	-17,200,000	-16,100,000	-13,300,000	-12,100,000	-22,200,000		-23,500,000	-16,600,000	-29,200,000		-17,500,000	-17,600,000	-28,700,000		-25,900,000	-16,600,000	-36,700,000		-22,000,000	-25,100,000	-21,000,000		-18,200,000	-15,800,000	-30,200,000		-28,700,000	-26,700,000	-19,000,000		-21,400,000	-39,900,000	-14,200,000	-16,700,000	-13,000,000	83,000,000	-63,000,000	-76,000,000	-47,000,000
free cash flows
acquisitions, net of cash acquired	1,700,000	-1,900,000	0	-457,300,000	100,000	-407,600,000	0	0			0	0							0	0	0	-4,700,000		-25,800,000								0	0	-113,700,000		-8,600,000	0	-200,000		0													293,000,000	-308,000,000
net cash – investing activities	-16,300,000	-40,700,000	-23,300,000	-334,000,000	-25,300,000	-435,300,000	-39,000,000	-22,200,000	-91,300,000	-28,500,000	-10,300,000	-26,400,000	-189,000,000	-29,400,000	-28,400,000	-19,200,000	-17,600,000	-17,100,000	-15,400,000	-13,300,000	-10,900,000	-26,200,000		-48,500,000	-103,500,000	-28,800,000		24,300,000	-17,200,000	-28,200,000		-24,800,000	-14,400,000	-150,100,000		-25,700,000	28,000,000	-24,800,000		28,800,000	-100,200,000	-40,000,000		100,000	-59,100,000	26,500,000		-85,200,000	-232,100,000	-13,900,000	-16,700,000	-12,000,000	354,000,000	-362,000,000	-67,000,000	-32,000,000
financing activities
commercial paper, net borrowings	-317,600,000	291,800,000	64,800,000	5,200,000	34,800,000	134,700,000		-143,300,000	11,800,000	-72,800,000	-103,400,000	-1,500,000	73,900,000	290,700,000	0	0	138,000,000	-42,600,000	-17,600,000	-20,300,000				-22,200,000							31,400,000	8,100,000	10,900,000	-1,500,000	-37,500,000	33,000,000	-5,000,000	28,500,000
long-term debt issued, net of debt issuance costs			1,500,000	463,300,000	0	299,100,000
long-term debt repayments	-131,200,000	-229,300,000	-236,100,000
share repurchases under repurchase plan	-400,800,000	-100,000,000	-500,000	-25,000,000			0	0	-30,000,000	-30,000,000	300,000	-4,700,000	-77,000,000	-163,900,000
payments for taxes related to net share settlement of stock incentive plans	-400,000	-13,000,000	-1,000,000	-400,000	-300,000	-12,500,000	-500,000	-300,000	-100,000	-6,300,000	-300,000
dividends paid	-27,500,000	-28,700,000	-26,000,000	-26,100,000	-26,100,000	-26,500,000	-23,900,000	-23,800,000	-23,900,000	-24,200,000	-21,800,000	-21,800,000	-21,900,000	-22,400,000	-18,800,000	-18,900,000	-19,000,000	-19,100,000	-29,300,000	-15,100,000	-14,400,000	-200,000		0	-12,900,000	-13,200,000		-11,900,000	-11,800,000	-200,000		-11,200,000	-11,400,000	-200,000		-100,000	-11,100,000	-11,400,000		-10,600,000				-10,100,000				-9,000,000	-17,000,000	0	-8,200,000	-9,000,000	-9,000,000	-46,000,000	-46,000,000	-92,000,000
net cash – financing activities	-128,700,000	-79,900,000	-197,100,000	218,200,000	-109,600,000	323,400,000	-87,100,000	-168,900,000	-43,400,000	-132,900,000	-126,300,000	-27,500,000	-26,100,000	96,600,000	-25,600,000	-69,100,000	117,700,000	-122,800,000	-48,700,000	-151,100,000	-170,800,000	212,000,000		-37,300,000	21,400,000	-21,000,000		-72,100,000	-31,800,000	27,700,000		-27,400,000	-51,600,000	3,700,000		-10,600,000	-84,700,000	16,900,000	210,600,000	-70,600,000	-53,600,000	34,000,000		-38,700,000	-21,800,000	-3,400,000		26,900,000	-57,300,000	-35,300,000	-29,400,000	14,000,000	-467,000,000	1,712,000,000	-51,000,000	8,000,000
exchange rate effects on cash and cash equivalents	19,600,000	7,900,000	-24,600,000	12,800,000	-5,200,000	-12,000,000	14,000,000	-10,000,000	-4,700,000	4,300,000	20,500,000	-18,200,000	-26,600,000	-1,500,000	-4,100,000	-9,300,000	1,200,000	-10,400,000	23,000,000	12,400,000	11,500,000	-11,700,000		-11,200,000	-100,000	700,000		-2,800,000	-16,800,000	8,200,000	-2,500,000	7,100,000	7,300,000	7,900,000		5,000,000	-5,900,000	9,900,000		-9,900,000	1,800,000	-15,800,000		-13,500,000	100,000	-1,700,000		6,100,000	4,800,000	1,500,000	-29,300,000	19,000,000	-4,000,000	-72,000,000	21,000,000	46,000,000
net cash – operating activities of discontinued operations				-300,000	0	-100,000		0	-100,000	-100,000				-100,000		900,000	-100,000	-100,000		100,000	-100,000	200,000		-100,000	1,600,000	-400,000		-500,000	-200,000	-1,200,000		-300,000	-100,000	-800,000		-1,300,000	-900,000	7,500,000		1,600,000	-2,000,000	-300,000		-600,000	-4,100,000	-400,000
net change in cash and cash equivalents	28,200,000	700,000	-21,900,000	20,600,000	17,600,000	-66,200,000	58,200,000	-31,300,000	200,000	-99,100,000	46,600,000	-11,200,000	-184,700,000	62,900,000	61,500,000	7,000,000	-201,200,000	-79,600,000	77,500,000	-36,900,000	-20,700,000	227,800,000	56,200,000	23,500,000	-21,600,000	-7,400,000	35,200,000	76,200,000	10,900,000	48,900,000		40,300,000	6,800,000	-112,200,000	-15,100,000	42,500,000	2,400,000	15,200,000		7,500,000	-72,700,000	-13,900,000	61,400,000	-5,100,000	12,600,000	7,800,000		-37,100,000	-217,400,000	22,900,000	11,200,000	38,000,000	-1,170,000,000	1,526,000,000	86,000,000	42,000,000
less: cash classified within current assets held for sale
cash and cash equivalents – beginning of year	0	440,000,000	0	0	0	489,900,000	0	0	0	561,900,000	0	0	0	648,300,000	0	0	0	860,600,000	0	0	0	612,900,000	0	0	0	562,200,000	0	0	0	391,000,000	0	0	0	460,700,000	0	0	0	415,700,000	0	0	0	584,000,000	0	0	0	507,300,000	0	0	-100,000	0	-100,000	690,000,000	-826,000,000	0	0	1,032,000,000
cash and cash equivalents – end of period	28,200,000	440,700,000		35,500,000	2,700,000	423,700,000		-31,300,000	200,000	462,800,000		-11,200,000	-184,700,000	711,200,000	61,500,000	7,000,000	-201,200,000	781,000,000	77,500,000	-36,900,000	-20,700,000	840,700,000	56,200,000	23,500,000	-21,600,000	554,800,000	35,200,000	76,200,000	10,900,000	439,900,000	-5,800,000	40,300,000	6,800,000	348,500,000	-15,100,000	42,500,000	2,400,000	430,900,000	-89,200,000	7,500,000	-72,700,000	570,100,000	61,400,000	-5,100,000	12,600,000	515,100,000		-37,100,000		22,900,000	11,100,000	728,000,000		1,526,000,000	86,000,000	1,074,000,000
supplemental disclosures of cash flow and non-cash information:
cash paid for interest	11,800,000	9,100,000	12,100,000	7,600,000	10,000,000	3,700,000
cash paid for income taxes, net of refunds received	51,600,000	17,600,000	21,800,000	37,000,000	53,500,000	16,300,000
capital expenditures included in current liabilities	2,500,000	13,900,000
deferred income tax expense
(gain) loss on sale of businesses
gain on sale of long-lived assets
proceeds from sale of business							1,000,000	0
proceeds from sale of long-lived assets																							-500,000
payments to acquire interest in unconsolidated subsidiaries							-1,100,000	0			0	-500,000
net cash from discontinued operations – operating activities
cash and cash equivalents – end of year
capital expenditures included in accounts payable					4,900,000	17,500,000
gain on sale of business								0
proceeds from sale of business, net of cash divested
long-term debt, repayments					-38,800,000	-70,500,000					-1,000,000	0			-1,100,000	0	-1,200,000	-100,000	-1,200,000	-100,000				-100,000	-1,800,000	-200,000		-200,000	-400,000	-1,500,000		-400,000	-400,000	-300,000		-200,000
cash paid during the year for:
asbestos-related (benefit) costs															0						16,000,000	-40,700,000							13,500,000	-19,700,000
contribution to divest asbestos-related assets and liabilities
(repayments of)/proceeds from commercial paper
supplemental disclosures of cash flow information
interest								3,800,000	4,300,000	4,200,000	5,100,000	3,100,000	2,100,000	500,000	0	2,600,000	500,000	200,000	700,000	1,400,000	-1,100,000	2,300,000	300,000	500,000	700,000	1,000,000	2,300,000	-100,000	100,000	1,000,000	1,000,000	700,000	1,100,000	1,000,000	1,200,000	900,000	1,000,000	1,400,000	3,300,000	500,000									1,500,000	100,000			34,000,000	4,000,000	39,000,000	3,000,000
income taxes, net of refunds received								19,200,000	39,600,000	13,200,000	29,200,000	18,300,000	36,700,000	8,500,000	11,100,000	7,900,000	28,900,000	13,400,000	20,200,000	30,200,000	2,700,000	8,000,000	15,500,000	14,200,000	24,400,000	9,300,000	22,500,000	7,800,000	16,200,000	7,000,000	22,400,000	17,700,000	8,700,000	13,200,000	18,900,000	22,000,000	10,200,000	5,000,000	23,800,000	18,000,000	7,700,000	-1,000,000			8,100,000	8,700,000	10,000,000	6,900,000	17,100,000	-28,500,000	10,500,000	-100,000,000
pension settlement charges
asset impairment charges																			0	0	0	16,300,000
contributions to postretirement plans																			-10,800,000
short-term revolving loans, borrowings																			0	0	117,500,000	378,300,000					0	0	0	246,500,000	0	0			0	0	0	27,700,000
short-term revolving loans, repayments																			0	-118,500,000								-210,300,000				-23,900,000				0	-50,600,000	-27,700,000
long-term debt, issued																			0				1,000,000	0	0	7,100,000						0	1,800,000	2,100,000
supplemental cash flow disclosures
asbestos-related benefit																											15,400,000
divestiture of asbestos-related assets and liabilities																0
asbestos-related costs (benefit)																		2,400,000	-50,400,000						11,800,000	12,600,000
share repurchases from net settlement of employee stock incentive plans													-100,000	-8,400,000
asbestos-related payments															0	-10,400,000	-2,900,000	-1,600,000	-900,000	-1,300,000	-1,500,000	-6,100,000		-4,300,000	-5,900,000	-9,900,000		-11,500,000	-18,000,000	-12,800,000		-8,800,000	-17,700,000	-13,000,000		-13,000,000	-7,200,000	-4,300,000		-8,700,000	-2,600,000	-3,900,000		-2,000,000	-4,400,000	-2,500,000		-7,500,000	8,100,000	-11,900,000	-300,000	-16,000,000
repurchase of common stock															-4,800,000	-50,300,000	-400,000	-61,000,000	-300,000	-200,000	-300,000	-83,400,000		-18,300,000	-100,000	-19,900,000		-400,000	-100,000	-55,300,000		-100,000	-30,500,000	-2,300,000		-43,400,000	-20,600,000	-6,900,000		-200,000	-900,000	-82,800,000		-10,600,000	-10,100,000	-4,800,000		0	-39,900,000	-100,000	-38,800,000	-38,000,000
proceeds from issuance of common stock																		200,000	2,600,000	1,600,000	0	100,000	3,300,000	3,300,000	3,200,000	5,100,000	0	1,100,000	4,100,000	600,000	4,500,000	200,000	600,000	5,900,000	3,500,000	0	2,700,000	6,100,000	700,000	200,000	3,300,000	2,000,000
adjustments to income from continuing operations
deferred income tax (benefit) expense
(gain) loss on sale or disposal of long-lived assets
cash paid (received) during the year for:
commercial paper, net repayments																						-82,700,000						146,400,000	0	-162,400,000
gain on sale or disposal of long-lived assets
asbestos-related (benefit) cost
commercial paper, net (repayments) borrowings
non-cash lease expense																										5,000,000
proceeds from sale of businesses and other assets																																			1,600,000	200,000			900,000	-300,000
purchases of investments																																				0	-20,600,000	-40,000,000		0	-57,700,000	-15,300,000		-44,500,000	-71,600,000	-49,000,000		-99,400,000
maturities of investments																																			9,900,000	4,900,000	72,400,000	36,300,000	10,300,000	47,600,000	15,300,000	5,300,000	62,000,000	71,200,000	38,600,000	97,200,000	83,400,000	34,900,000
long-term debt issued
long-term debt, repaid																																								-200,000	-1,700,000	-200,000		-500,000	-400,000	-300,000		-500,000		0
net income																												111,100,000	69,900,000	101,300,000	-67,100,000	86,900,000	47,900,000	45,600,000	26,100,000	90,200,000	33,000,000	37,300,000	36,500,000	130,700,000	142,400,000	42,000,000	34,200,000	80,700,000	38,700,000	33,200,000	12,400,000	431,400,000	32,400,000	73,000,000	17,000,000	3,000,000	-500,000,000	78,000,000	168,000,000	124,000,000
less: income from discontinued operations																													0	100,000		-100,000	-100,000	-100,000	2,200,000	1,800,000	500,000	-300,000	100,000	34,200,000	1,700,000	3,400,000		-300,000	-2,900,000	-1,000,000	300,000	-2,300,000	10,600,000	12,200,000	100,000	-7,000,000	443,000,000	7,000,000	0	-2,000,000
less: income attributable to noncontrolling interests																												200,000	200,000	100,000		0			300,000	100,000						-100,000	500,000	400,000	400,000	1,000,000	1,200,000	700,000
change in accrued and deferred income taxes																												17,700,000	-11,800,000	100,000		22,900,000	1,500,000	-4,600,000		23,600,000	6,300,000	3,400,000		-8,500,000	13,200,000	17,200,000		4,800,000	1,900,000	-1,700,000		-357,400,000		18,900,000	26,700,000	108,000,000
deferred income taxes
change in accrued income taxes
proceeds from insurance recovery																																							1,700,000	0
excess tax benefit from equity compensation activity																																			-200,000	0	400,000	3,000,000	200,000	200,000	1,200,000	1,800,000	2,000,000	2,000,000	1,200,000	5,200,000	3,400,000	1,600,000
stock-based compensation																																5,200,000	3,600,000	3,700,000		3,200,000	3,000,000	2,900,000		4,200,000	3,800,000	3,100,000	3,200,000	4,000,000	3,500,000	3,300,000	3,400,000	3,500,000	3,000,000	3,600,000	2,800,000	3,000,000	-10,000,000	7,000,000	8,000,000	7,000,000
proceeds from sale of assets
asbestos-related costs																																	14,900,000	14,900,000				12,800,000			-84,800,000	15,400,000			15,900,000	15,800,000	16,300,000	-15,400,000	15,800,000	12,800,000	9,300,000	13,000,000
less: loss attributable to noncontrolling interests																																		-400,000
less: (loss) attributable to noncontrolling interests																																						-100,000
income from continuing operations attributable to itt corporation																																						37,700,000	36,600,000	96,500,000	140,600,000	38,700,000	33,400,000	80,600,000	41,200,000	33,200,000	10,900,000	433,000,000
net cash – discontinued operations																																																-14,700,000	-2,800,000	-3,400,000	1,500,000	-1,000,000
short-term debt																																								-58,200,000	-44,800,000	113,500,000		-22,500,000	-4,500,000	-11,000,000	-28,100,000	26,200,000	-22,600,000	-40,000,000	16,800,000	21,000,000	-15,000,000	-46,000,000	-10,000,000	74,000,000
changes in assets and liabilities
proceeds from sale of discontinued operations and other assets																																																	39,100,000	100,000
long-term debt repaid																																																					-1,251,000,000
discontinued operations:
issuance of common stock																																												2,900,000	2,400,000	9,000,000		6,100,000		4,500,000	700,000	35,000,000		7,000,000	8,000,000	33,000,000
interest paid
income taxes paid, net of
interest paid, net of interest received																																													0	100,000		500,000
transformation costs																																																	1,100,000	2,600,000	4,300,000	5,000,000				55,000,000
transformation-related payments																																																	-3,100,000	-3,900,000	-10,300,000	-30,000,000
contributions from exelis and xylem
distributions of exelis and xylem
less: cash and cash equivalents distributed to exelis and xylem
cash and cash equivalents of continuing operations – end of period																																																	-217,500,000	22,900,000	11,100,000	728,000,000
contributions to pension plans																																																-800,000		-300,000	-800,000	-32,000,000
discontinued operations
income from continuing operations																																																	21,800,000	60,800,000	16,900,000	10,000,000	-943,000,000	71,000,000	168,000,000	126,000,000
tax benefit from share-based compensation
less: cash and cash equivalents of discontinued operations – end of period
distribution of exelis and xylem
tax impact from equity compensation activity																																																		500,000
restructuring and asset impairment charges
restructuring payments
income taxes																																																					-29,000,000	16,000,000	136,000,000	17,000,000
non-cash adjustments to income from continuing operations:
non-cash transformation costs																																																						9,000,000
proceeds from sale of assets and businesses
net cash from discontinued operations																																																						0
payments for restructuring
change in accrued liabilities
change in accrued taxes
change in other assets
change in other liabilities
change in accrued and deferred taxes
net cash — operating activities
net cash — investing activities
tax impact from stock-based compensation
net cash — financing activities
cash and cash equivalents — beginning of period
cash and cash equivalents — end of period
cash paid during the period for:
tax benefit from stock option exercises and restricted stock award lapses
net cash – discontinued operations:
income from discontinued operations
change in other current and non-current assets
change in other current and non-current liabilities
tax impact from stock option exercises and restricted stock lapses
loss (income) from discontinued operations
change in accounts payable and accrued expenses
tax impact from stock option exercises and restricted stock award lapses
net cash — discontinued operations — operating activities
additions to plant, property and equipment
adjustments to reconcile income from continuing operations to net cash from operating activities:
change in non-current liabilities
additions to plant, property, and equipment
foreign exchange rate effects on cash and cash equivalents
net cash — discontinued operations:
cumulative effect of change in accounting principle
(income) income from discontinued operations
cash and cash equivalents — beginning of year
cash and cash equivalents — end of year
tax benefit from stock option exercises
(income) from discontinued operations
amortization of stock compensation
net cash — discontinued operations operating activities
net cash — discontinued operations investing activities
net cash — discontinued operations financing activities
supplemental disclosures of cash flow information:

We provide you with 20 years of cash flow statements for ITT stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ITT stock. Explore the full financial landscape of ITT stock with our expertly curated income statements.

The information provided in this report about ITT stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.